(BMT) British American Tobacco - Overview
Sector: Consumer Defensive | Industry: Tobacco | Exchange: XETRA (Germany) | Market Cap: 123.263m EUR | Total Return: 53.8% in 12m
Cigarettes, Vapour Products, Nicotine Pouches, Heated Tobacco, Snuff
Total Rating 63
Safety 76
Buy Signal 0.03
Tobacco
Industry Rotation: +36.6
Industry Rotation: +36.6
Market Cap:
143B
Avg Turnover: 5.39M
Avg Turnover: 5.39M
Risk 3d forecast
Volatility19.5%
VaR 5th Pctl3.27%
VaR vs Median1.57%
Reward TTM
Sharpe Ratio1.87
Rel. Str. IBD73.7
Rel. Str. Peer Group86.8
Character TTM
Beta-0.127
Beta Downside-0.248
Hurst Exponent0.474
Drawdowns 3y
Max DD13.98%
CAGR/Max DD2.39
CAGR/Mean DD7.52
EPS (Earnings per Share)
Revenue
Rev. CAGR: 5.70%
Rev. Trend: 65.8%
Rev. Trend: 65.8%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Description: BMT British American Tobacco
British American Tobacco p.l.c. (BMT) is a global consumer goods company specializing in the manufacture and distribution of tobacco and nicotine products. Its portfolio includes traditional combustible cigarettes, fine-cut tobacco, and New Category products such as vapor, heated tobacco, and modern oral nicotine pouches. The company operates an extensive international supply chain, distributing major brands like Dunhill, Lucky Strike, and Vuse to retail outlets across six continents.
The tobacco sector is currently undergoing a structural transition as companies shift capital allocation from legacy combustibles toward reduced-risk alternatives to address changing regulatory landscapes and consumer preferences. British American Tobacco utilizes a multi-category business model, leveraging its established distribution networks to scale these newer technologies while maintaining high margins from its traditional tobacco brands. Investors may find additional performance metrics and peer comparisons by visiting ValueRay.
- Accelerated transition to New Categories revenue offsets declining global combustible volumes
- US menthol ban litigation creates significant regulatory uncertainty for premium brand portfolio
- Deleveraging and free cash flow generation support high dividend yield and buybacks
- Strategic investment in heated tobacco and nicotine pouches drives non-combustible margin expansion
- Emerging market currency volatility impacts reported revenue and earnings per share figures
Piotroski VR‑10 (Strict)
5.5
| Net Income: 10.81b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 0.09 > 1.0 |
| NWC/Revenue: -3.57% < 20% (prev -5.37%; Δ 1.80% < -1%) |
| CFO/TA 0.13 > 3% & CFO 14.32b > Net Income 10.81b |
| Net Debt (31.95b) to EBITDA (17.14b): 1.86 < 3 |
| Current Ratio: 0.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.19b) vs 12m ago -1.86% < -2% |
| Gross Margin: 73.22% > 18% (prev 0.82%; Δ 7.24k% > 0.5%) |
| Asset Turnover: 45.03% > 50% (prev 33.82%; Δ 11.21% > 0%) |
| Interest Coverage Ratio: 3.30 > 6 (EBITDA TTM 17.14b / Interest Expense TTM 3.75b) |
Altman Z''
2.08
| A: -0.02 (Total Current Assets 12.68b - Total Current Liabilities 14.52b) / Total Assets 109.29b |
| B: 0.21 (Retained Earnings 22.93b / Total Assets 109.29b) |
| C: 0.11 (EBIT TTM 12.39b / Avg Total Assets 114.33b) |
| D: 0.74 (Book Value of Equity 45.44b / Total Liabilities 61.15b) |
| Altman-Z'' Score: 2.08 = BBB |
Beneish M
-2.89
| DSRI: 0.82 (Receivables 3.80b/3.64b, Revenue 51.49b/40.37b) |
| GMI: 1.12 (GM 73.22% / 81.93%) |
| AQI: 1.02 (AQ_t 0.84 / AQ_t-1 0.83) |
| SGI: 1.28 (Revenue 51.49b / 40.37b) |
| TATA: -0.03 (NI 10.81b - CFO 14.32b) / TA 109.29b) |
| Beneish M-Score: -2.89 (Cap -4..+1) = A |
What is the price of BMT shares?
As of May 21, 2026, the stock is trading at EUR 56.72 with a total of 89,292 shares traded.
Over the past week, the price has changed by +2.53%, over one month by +16.85%, over three months by +9.57% and over the past year by +53.83%.
Over the past week, the price has changed by +2.53%, over one month by +16.85%, over three months by +9.57% and over the past year by +53.83%.
Is BMT a buy, sell or hold?
British American Tobacco has no consensus analysts rating.
What are the forecasts/targets for the BMT price?
| Analysts Target Price | - | - |
British American Tobacco (BMT) - Fundamental Data Overview
as of 20 May 2026
Market Cap USD = 143.29b (123.26b EUR * 1.1625 EUR.USD)Market Cap GBP = 106.66b (123.26b EUR * 0.8653 EUR.GBP)
P/E Trailing = 14.25
P/E Forward = 11.7786
P/S = 4.8131
P/B = 1.9365
P/EG = 1.4861
Revenue TTM = 51.49b GBP
EBIT TTM = 12.39b GBP
EBITDA TTM = 17.14b GBP
Long Term Debt = 31.33b GBP (from longTermDebt, last quarter)
Short Term Debt = 3.36b GBP (from shortTermDebt, last quarter)
Debt = 35.77b GBP (from shortLongTermDebtTotal, last quarter)
Net Debt = 31.95b GBP (from netDebt column, last quarter)
Enterprise Value = 138.59b GBP (106.66b + Debt 35.77b - CCE 3.84b)
Interest Coverage Ratio = 3.30 (Ebit TTM 12.39b / Interest Expense TTM 3.75b)
EV/FCF = 9.84x (Enterprise Value 138.59b / FCF TTM 14.09b)
FCF Yield = 10.16% (FCF TTM 14.09b / Enterprise Value 138.59b)
FCF Margin = 27.36% (FCF TTM 14.09b / Revenue TTM 51.49b)
Net Margin = 21.00% (Net Income TTM 10.81b / Revenue TTM 51.49b)
Gross Margin = 73.22% ((Revenue TTM 51.49b - Cost of Revenue TTM 13.79b) / Revenue TTM)
Gross Margin QoQ = 61.14% (prev 83.59%)
Tobins Q-Ratio = 1.27 (Enterprise Value 138.59b / Total Assets 109.29b)
Interest Expense / Debt = 2.34% (Interest Expense 836.5m / Debt 35.77b)
Taxrate = 25.32% (1.09b / 4.29b)
NOPAT = 9.26b (EBIT 12.39b * (1 - 25.32%))
Current Ratio = 0.87 (Total Current Assets 12.68b / Total Current Liabilities 14.52b)
Debt / Equity = 0.75 (Debt 35.77b / totalStockholderEquity, last quarter 47.93b)
Debt / EBITDA = 1.86 (Net Debt 31.95b / EBITDA 17.14b)
Debt / FCF = 2.27 (Net Debt 31.95b / FCF TTM 14.09b)
Total Stockholder Equity = 49.64b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.46% (Net Income 10.81b / Total Assets 109.29b)
RoE = 21.78% (Net Income TTM 10.81b / Total Stockholder Equity 49.64b)
RoCE = 15.31% (EBIT 12.39b / Capital Employed (Equity 49.64b + L.T.Debt 31.33b))
RoIC = 15.88% (NOPAT 9.26b / Invested Capital 58.27b)
WACC = 4.58% (E(106.66b)/V(142.43b) * Re(5.53%) + D(35.77b)/V(142.43b) * Rd(2.34%) * (1-Tc(0.25)))
Discount Rate = 5.53% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: -70.47 | Cagr: -1.40%
[DCF] Terminal Value 87.44% ; FCFF base≈14.56b ; Y1≈16.40b ; Y5≈22.08b
[DCF] Fair Price = 284.9 (EV 647.95b - Net Debt 31.95b = Equity 616.00b / Shares 2.16b; r=6.0% [WACC]; 5y FCF grow 14.69% → 3.0% )
Revenue Correlation: 65.77 | Revenue CAGR: 5.70% | SUE: N/A | # QB: 0